ANDREW L. PECORA, MD, FACP

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

LISATA THERAPEUTICS, INC.

Filing Date Source Excerpt
2016-05-10 Andrew L. Pecora, MD, FACP Andrew L. Pecora, MD, FACP was appointed to the Board on December 8, 2011... The Board also maintains the following additional committee: Science and Technology Committee: The Science and Technology Committee consists of four directors: Drs. Traber (chairperson), Mazzo, Preti and Pecora... The following table sets forth information on all compensation to Caladrius' directors (other than as reflected in the Summary Compensation Table) for the year ended December 31, 2015... Andrew Pecora (9) $13,333 $0 $181,095 $194,428

Data sourced from SEC filings. Last updated: 2025-08-30